About Hematology-Oncology & SCT Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hematology-Oncology & SCT Research Center
During the past decade, Hematology-Oncology & SCT Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure
2008-02-01
2015-06-01
Completed
1,325
Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
2012-08-01
2015-06-01
Completed
312
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
2007-11-01
2013-05-01
Completed
6,876
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology-Oncology & SCT Research Center"
#1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hematology-Oncology & SCT Research Center
According to Clinical.Site data, the most researched conditions in "Hematology-Oncology & SCT Research Center" are
"Bone Marrow Transplantation" (2 trials), "Leukemia, Myeloid, Chronic" (2 trials), "Mucositis" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Beta-Thalassemia" (1 trials). Many other conditions were trialed in "Hematology-Oncology & SCT Research Center" in a lesser frequency.
Clinical Trials Intervention Types at Hematology-Oncology & SCT Research Center
Most popular intervention types in "Hematology-Oncology & SCT Research Center" are "Drug" (6 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "131I-MIBG , Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation" (1 trials), "Allogeneic bone marrow transplantation" (1 trials), "Autologous bone marrow transplantation" (1 trials) and "Bcr-abl multipeptide vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hematology-Oncology & SCT Research Center
The vast majority of trials in "Hematology-Oncology & SCT Research Center" are
9 trials for "All" genders.
Clinical Trials Status at Hematology-Oncology & SCT Research Center
Currently, there are NaN active trials in "Hematology-Oncology & SCT Research Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hematology-Oncology & SCT Research Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hematology-Oncology & SCT Research Center, 3 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".